Your browser doesn't support javascript.
loading
The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
Lang, Guan-Tian; Shi, Jin-Xiu; Hu, Xin; Zhang, Chen-Hui; Shan, Ling; Song, Chuan-Gui; Zhuang, Zhi-Gang; Cao, A-Yong; Ling, Hong; Yu, Ke-Da; Li, Shan; Sun, Meng-Hong; Zhou, Xiao-Yan; Huang, Wei; Shao, Zhi-Ming.
Affiliation
  • Lang GT; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Shi JX; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Hu X; Department of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center and Shanghai Industrial Technology Institute (SITI), Shanghai, People's Republic of China.
  • Zhang CH; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Shan L; Department of Genetics, Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center and Shanghai Industrial Technology Institute (SITI), Shanghai, People's Republic of China.
  • Song CG; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Zhuang ZG; Department of Breast Surgery, Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
  • Cao AY; Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
  • Ling H; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Yu KD; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Li S; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Sun MH; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Zhou XY; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Huang W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Shao ZM; Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Int J Cancer ; 141(1): 129-142, 2017 07 01.
Article in En | MEDLINE | ID: mdl-28294317
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / Genetic Predisposition to Disease / BRCA2 Protein Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Cancer Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / Genetic Predisposition to Disease / BRCA2 Protein Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Cancer Year: 2017 Document type: Article